Comprehensive genomic profiling in advanced/metastatic colorectal cancer: Number needed to test and budget impact of expanded first-line use.

David Proudman, Nicholas C DeVito,Suzanne Belinson, Mina Alsaraf Allo, Eric D Morris,James Signorovitch,Anuj K Patel

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 2|浏览7

暂无评分

摘要

Replacing 20% of usual testing with Tempus xT CGP was associated with a small incremental testing cost and can identify meaningfully more actionable alterations.

查看译文

关键词

Colorectal cancer,I,I1,I10,I13,budget impact model,comprehensive genomic profiling,molecular testing,next generation sequencing,testing cost

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要